134 related articles for article (PubMed ID: 9342097)
21. Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.
Jonson SD; Bonasera TA; Dehdashti F; Cristel ME; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 1999 Jan; 26(1):123-30. PubMed ID: 10096512
[TBL] [Abstract][Full Text] [Related]
22. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.
Cremerius U; Bares R; Weis J; Sabri O; Mull M; Schröder JM; Gilsbach JM; Buell U
J Nucl Med; 1997 Jan; 38(1):26-30. PubMed ID: 8998144
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
[TBL] [Abstract][Full Text] [Related]
24. Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas.
Henn W; Cremerius U; Heide G; Lippitz B; Schröder JM; Gilsbach JM; Büll U; Zang KD
Cancer Genet Cytogenet; 1995 Feb; 79(2):144-8. PubMed ID: 7889508
[TBL] [Abstract][Full Text] [Related]
25. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
[TBL] [Abstract][Full Text] [Related]
26. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
27. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.
Di Chiro G; Hatazawa J; Katz DA; Rizzoli HV; De Michele DJ
Radiology; 1987 Aug; 164(2):521-6. PubMed ID: 3496626
[TBL] [Abstract][Full Text] [Related]
28. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy.
Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ
J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164
[TBL] [Abstract][Full Text] [Related]
29. Uterine tumors: pathophysiologic imaging with 16alpha-[18F]fluoro-17beta-estradiol and 18F fluorodeoxyglucose PET--initial experience.
Tsujikawa T; Yoshida Y; Mori T; Kurokawa T; Fujibayashi Y; Kotsuji F; Okazawa H
Radiology; 2008 Aug; 248(2):599-605. PubMed ID: 18539894
[TBL] [Abstract][Full Text] [Related]
30. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and oestrogen receptors in meningiomas: biochemical and clinicopathological considerations.
Whittle IR; Foo MS; Besser M; Vanderfield GK
Aust N Z J Surg; 1984 Aug; 54(4):325-30. PubMed ID: 6593026
[TBL] [Abstract][Full Text] [Related]
32. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of estradiol and progesterone receptors in meningioma].
Lesch KP; Fahlbusch R
Neurochirurgia (Stuttg); 1986 Jul; 29(4):99-104. PubMed ID: 3748266
[TBL] [Abstract][Full Text] [Related]
34. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.
Dehdashti F; Mortimer JE; Siegel BA; Griffeth LK; Bonasera TJ; Fusselman MJ; Detert DD; Cutler PD; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1995 Oct; 36(10):1766-74. PubMed ID: 7562040
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Meningioma WHO Grade Using PET Findings: A Systematic Review and Meta-Analysis.
Slot KM; Verbaan D; Buis DR; Schoonmade LJ; Berckel BNM; Vandertop WP
J Neuroimaging; 2021 Jan; 31(1):6-19. PubMed ID: 33135239
[TBL] [Abstract][Full Text] [Related]
36. Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases.
Magdelenat H; Pertuiset BF; Poisson M; Martin PM; Philippon J; Pertuiset B; Buge A
Acta Neurochir (Wien); 1982; 64(3-4):199-213. PubMed ID: 7136865
[TBL] [Abstract][Full Text] [Related]
37. Progestin receptors in meningiomas. Comparison of cytosolic assays with immunocytochemical identification in cryostat and paraffin sections.
Blaauw G; Koudstaal J; Blankenstein MA; Debets-Te Baerts M; Gijzen AH
Acta Neurochir (Wien); 1995; 134(1-2):83-7. PubMed ID: 7668135
[TBL] [Abstract][Full Text] [Related]
38. Glucose and methionine uptake and proliferative activity in meningiomas.
Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
[TBL] [Abstract][Full Text] [Related]
39. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.
Kuratsu JI; Seto H; Kochi M; Ushio Y
Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837
[TBL] [Abstract][Full Text] [Related]
40. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA; Welch MJ; Dehdashti F
Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
